Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abecma
Manufacturing
BMS signs $380M deal with cell therapy manufacturer Cellares
BMS has expanded its partnership with innovative cell therapy manufacturer Cellares, signing a $380M deal for CAR-T manufacturing.
Kevin Dunleavy
Apr 22, 2024 11:10am
BMS' Abecma wins earlier myeloma nod with updated boxed warning
Apr 5, 2024 11:46am
FDA flags early deaths for multiple myeloma CAR-Ts
Mar 13, 2024 11:06am
Legend CEO offers preview of high-stakes FDA adcomm for Carvykti
Mar 11, 2024 1:29pm
FDA sets date for high-profile CAR-T advisory committee meeting
Feb 2, 2024 1:31pm
BMS CEO outlines transition strategy featuring 11 brands, BD
Feb 2, 2024 11:30am